Few studies have investigated quality of life (QoL) improvements in patients with colorectal cancer or the benefits of digital healthcare interventions. This randomized controlled trial assessed the impact of mobile applications on postoperative QoL…
Continue Reading
Is your practice’s front desk still drowning in busywork? Learn how one organization tackled inefficiency head-on with smarter digital check-in, targeted AI, and staff-driven innovation.In this video, you’ll hear how internal champions, not just…
Continue Reading
The Growing Insurance Coverage Dilemma
Americans with health insurance are facing what GoodRx researchers call “the big pinch” – a troubling intersection of limited medication coverage and restrictive access policies across commercial plans, Medicare, and…
The Maharashtra University of Health Sciences in India will embark on research to explore various clinical applications of an AI-powered tool for detecting emotions.It signed a memorandum of understanding with global IT consultant Nihilent,…
Continue Reading
HEALTHTECH: How do you connect different departments to test an AI solution? How are you getting user and executive buy-in?KOCZKA: At Northwestern Medicine, our structure is to have cross-functional teams evaluate solutions, developing from the…
Continue Reading
🎧 Subscribe to The Pulse by Wharton Digital Health on Apple, Spotify, Substack, or Twitter for more conversations with the leaders reshaping health tech.“Your muscle is your longevity organ.” — Dr. Rekha Kumar, Chief Medical Officer at FoundIn…
Continue Reading
Sapna Davies and Hannah Cheesman using the Apollo EPR system on Powys Ward (Credit: The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust)
The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS…
Continue Reading
For the 95th episode of the CIO podcast hosted by Healthcare IT Today, we are joined by Christian Lindmark, CTO at Stanford Health Care and Stanford School of Medicine, to talk about private 5G…
Continue Reading
Determining tumor microsatellite status has significant clinical value because tumors that are microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) respond well to immune checkpoint inhibitors (ICIs) and oftentimes not to chemotherapeutics. We propose…
Continue Reading
Josh Canavan, Head of Pharmacy at RazorMetrics
Millions of Americans are currently facing a difficult choice: either pay for expensive biologic medications or ration doses to afford basic needs. Cost-related nonadherence (CRN) is where patients…
Continue Reading
